Viagra experienced no impact on saquinavir pharmacokinetics. A more powerful CYP3A4 inhibitor such as ketoconazole or itraconazole may be predicted to acquire larger influence than that viewed with saquinavir. Populace pharmacokinetic information from patients in scientific trials also indicated a reduction in sildenafil clearance when it was co-ad